OSD
Pharmaceutical companies are turning to third party service providers and CDMOs which have a standalone analytical offering that can alleviate some of the pressures on internal resource and reduce time to market.
Several CDMOs, like Recipharm, are in turn actively exploring more innovative ways to add value to their customer offerings. The emergence of more systematic approaches for example means that the automation of analytical instrumentation is becoming a reality.
In an article with Speciality Chemicals, our Assistant Vice President, Ramesh Jagadeesan, discusses innovative approaches to optimise analytical chemistry.
Click the link to read more in the digital magazine on page 15, 28-30